Variant report
Variant | esv3375452 |
---|---|
Chromosome Location | chr1:166495343-166534187 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:65)
- CpG islands (count:0)
- Chromatin interactive region (count:16)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr1:166530687-166530718 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr1:166525520-166525829 | K562 | blood: | n/a | n/a |
3 | CBX3 | chr1:166525579-166525895 | K562 | blood: | n/a | n/a |
4 | CBX3 | chr1:166505601-166505971 | K562 | blood: | n/a | n/a |
5 | CBX3 | chr1:166500999-166501356 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr1:166521991-166522172 | HepG2 | liver: | n/a | chr1:166522076-166522087 |
7 | CEBPB | chr1:166497724-166497840 | IMR90 | lung: | n/a | n/a |
8 | CEBPB | chr1:166497614-166497843 | K562 | blood: | n/a | n/a |
9 | CEBPB | chr1:166497618-166497854 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | CEBPB | chr1:166531518-166531646 | A549 | lung: | n/a | n/a |
11 | CEBPB | chr1:166521965-166522147 | K562 | blood: | n/a | chr1:166522076-166522087 |
12 | CTCF | chr1:166496860-166496923 | K562 | blood: | n/a | n/a |
13 | CTCF | chr1:166520940-166521090 | WERI-Rb-1 | eye: | n/a | n/a |
14 | CTCF | chr1:166496863-166496945 | LNCaP | prostate: | n/a | n/a |
15 | CTCF | chr1:166496547-166496588 | Kidney_OC | kidney: | n/a | n/a |
16 | CTCF | chr1:166496740-166496890 | HMEC | breast: | n/a | n/a |
17 | CTCF | chr1:166510087-166510119 | GM20000 | blood: | n/a | n/a |
18 | CTCF | chr1:166496800-166496950 | HMEC | breast: | n/a | n/a |
19 | CUX1 | chr1:166533129-166533166 | K562 | blood: | n/a | n/a |
20 | E2F4 | chr1:166525978-166526086 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | E2F4 | chr1:166507196-166507522 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | EP300 | chr1:166528023-166528050 | K562 | blood: | n/a | n/a |
23 | EP300 | chr1:166497478-166497492 | K562 | blood: | n/a | n/a |
24 | FOXA2 | chr1:166521152-166521594 | A549 | lung: | n/a | n/a |
25 | GATA3 | chr1:166505367-166505465 | SH-SY5Y | brain: | n/a | n/a |
26 | GATA3 | chr1:166510467-166510480 | SH-SY5Y | brain: | n/a | n/a |
27 | KAP1 | chr1:166500786-166501587 | K562 | blood: | n/a | n/a |
28 | KAP1 | chr1:166505252-166506479 | K562 | blood: | n/a | n/a |
29 | KAP1 | chr1:166507597-166507797 | K562 | blood: | n/a | n/a |
30 | KAP1 | chr1:166525239-166526151 | K562 | blood: | n/a | n/a |
31 | MAFF | chr1:166525306-166525587 | K562 | blood: | n/a | n/a |
32 | MAFF | chr1:166507972-166508259 | K562 | blood: | n/a | n/a |
33 | MAFF | chr1:166525309-166525572 | HepG2 | liver: | n/a | n/a |
34 | MAFF | chr1:166508042-166508242 | HepG2 | liver: | n/a | n/a |
35 | MAFK | chr1:166507955-166508265 | IMR90 | lung: | n/a | n/a |
36 | MAFK | chr1:166507990-166508250 | HepG2 | liver: | n/a | n/a |
37 | MAFK | chr1:166507917-166508266 | HepG2 | liver: | n/a | n/a |
38 | MAFK | chr1:166525290-166525610 | IMR90 | lung: | n/a | n/a |
39 | MAFK | chr1:166531973-166532119 | HepG2 | liver: | n/a | n/a |
40 | MAFK | chr1:166525377-166525557 | K562 | blood: | n/a | n/a |
41 | MAFK | chr1:166525284-166525602 | HepG2 | liver: | n/a | n/a |
42 | MAFK | chr1:166525338-166525559 | HepG2 | liver: | n/a | n/a |
43 | MAFK | chr1:166507968-166508202 | K562 | blood: | n/a | n/a |
44 | MYC | chr1:166501369-166501668 | A549 | lung: | n/a | n/a |
45 | POLR2A | chr1:166525248-166525332 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | POLR2A | chr1:166497364-166497410 | Hela-S3 | cervix: | n/a | n/a |
47 | POLR2A | chr1:166523501-166523540 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | POLR2A | chr1:166497315-166497679 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | POLR2A | chr1:166533229-166533350 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr1:166527108-166527201 | A549 | lung: | n/a | n/a |
No data |
(count:16 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:166525439..166528045-chr1:166531507..166534045,2 | K562 | blood: | |
2 | chr1:166498822..166501708-chr1:166502743..166504796,2 | MCF-7 | breast: | |
3 | chr1:166503141..166505252-chr1:166506106..166508917,2 | K562 | blood: | |
4 | chr1:166503141..166505252-chr1:166506106..166508917,2 | K562 | blood: | |
5 | chr1:166507154..166509777-chr1:166808647..166811411,2 | K562 | blood: | |
6 | chr1:166519753..166521489-chr1:166523362..166525642,2 | K562 | blood: | |
7 | chr1:166519753..166521489-chr1:166523362..166525642,2 | K562 | blood: | |
8 | chr1:166498822..166501708-chr1:166502743..166504796,2 | MCF-7 | breast: | |
9 | chr1:166512826..166515728-chr1:166533792..166536212,2 | K562 | blood: | |
10 | chr1:166525448..166527938-chr1:166528907..166531054,2 | K562 | blood: | |
11 | chr1:166525439..166528045-chr1:166531507..166534045,2 | K562 | blood: | |
12 | chr1:166528353..166531255-chr1:166533541..166536612,3 | K562 | blood: | |
13 | chr1:166525448..166527938-chr1:166528907..166531054,2 | K562 | blood: | |
14 | chr1:166491898..166494773-chr1:166503780..166506607,2 | K562 | blood: | |
15 | chr1:166436743..166438384-chr1:166525102..166527885,2 | K562 | blood: | |
16 | chr1:166526359..166528969-chr1:166551076..166553291,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
FMO8P | TF binding region |
ENSG00000143157 | chromatin interactions |
ENSG00000238087 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573665581 | chr1:166495347-166495348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148208337 | chr1:166495385-166495386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149535053 | chr1:166495395-166495396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs67241036 | chr1:166495399-166495400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368080703 | chr1:166496403-166496404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113002076 | chr1:166496493-166496494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376371217 | chr1:166496506-166496507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371845542 | chr1:166496544-166496545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190899467 | chr1:166496550-166496551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544396366 | chr1:166496556-166496557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146403825 | chr1:166496582-166496583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183138981 | chr1:166496583-166496584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4657568 | chr1:166496594-166496595 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs559850547 | chr1:166496596-166496597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555370264 | chr1:166496619-166496620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528805795 | chr1:166496644-166496645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551754901 | chr1:166496671-166496672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565559299 | chr1:166496676-166496677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567511834 | chr1:166496677-166496678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187429475 | chr1:166496686-166496687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144237766 | chr1:166496735-166496736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34405988 | chr1:166496752-166496753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4656504 | chr1:166496788-166496789 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs567461904 | chr1:166496798-166496799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565709615 | chr1:166496804-166496805 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144238125 | chr1:166496850-166496851 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556367495 | chr1:166496894-166496895 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148734400 | chr1:166496954-166496955 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193077500 | chr1:166496994-166496995 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539006011 | chr1:166496995-166496996 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558605190 | chr1:166497033-166497034 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577941587 | chr1:166497041-166497042 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545110416 | chr1:166497046-166497047 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557367094 | chr1:166497053-166497054 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371128737 | chr1:166497054-166497055 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7556345 | chr1:166497055-166497056 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs142361896 | chr1:166497076-166497077 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554761909 | chr1:166497083-166497084 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574591801 | chr1:166497084-166497085 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571946323 | chr1:166497086-166497087 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs151189860 | chr1:166497106-166497107 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553747634 | chr1:166497163-166497164 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576800687 | chr1:166497195-166497196 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545763277 | chr1:166497196-166497197 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184876235 | chr1:166497200-166497201 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs74975493 | chr1:166497233-166497234 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544411318 | chr1:166497244-166497245 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78682499 | chr1:166497380-166497381 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150013908 | chr1:166497430-166497431 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530149614 | chr1:166497431-166497432 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:166494800-166495400 | Enhancers | Liver | Liver |
2 | chr1:166496400-166496800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr1:166496400-166497000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr1:166496400-166498200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr1:166496600-166496800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr1:166496600-166497000 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr1:166496600-166498400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr1:166496800-166497000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
9 | chr1:166496800-166497200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
10 | chr1:166496800-166497600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr1:166496800-166498000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr1:166497000-166497200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr1:166497000-166497400 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
14 | chr1:166497200-166497600 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
15 | chr1:166497200-166498400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr1:166497400-166498400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr1:166497600-166498200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr1:166498200-166498400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
19 | chr1:166498400-166500200 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
20 | chr1:166498400-166500800 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
21 | chr1:166499800-166500400 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
22 | chr1:166500000-166500200 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
23 | chr1:166505600-166507200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr1:166513800-166514200 | Enhancers | K562 | blood |